Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine infusion for postoperative pain in gynecologic surgery
NCT04118777Withdrawn
- Sponsor
- University of Tennessee at Chattanooga
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of Tennessee at Chattanooga. Primary endpoint: Amount of rescue narcotics consumed in the postoperative period at 6 weeks. Planned start May 2020; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04118777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118777.